Comprehensive Development of CAR-T Cell Therapy in Taiwan：GDP Laboratory and Cell Processing_2023.11.22
Comprehensive Development of CAR-T Cell Therapy in Taiwan：DLBCL Disease Treatment Strategies and Optimization of Treatment Outcomes_2023.12.22
線上會議影音檔
Comprehensive Development of CAR-T Cell Therapy in Taiwan：Nursing Care for Patients and Side Effect Management_2023.12.06
線上會議影音檔
Reverse translational research of CAR-T therapy_2023.11.02
– Analysis of some 500 cases of CAR-T therapy for B-cell lymphoma in Japan –
Shin Kawamata, MD Phd
Comprehensive Development of CAR-T Cell Therapy in Taiwan：Recent Advances and Future Perspectives in CAR-T Cell Therapy Industry in Asia_2023.11.02
線上會議影音檔
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
Comprehensive Development of CAR-T Cell Therapy in Taiwan：Recent Advances and Future Perspectives in CAR-T Cell Therapy Industry in Asia
會議形式：Virtual Panel
Meeting（線上與談會議）
